Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)
In Millions, unless otherwise specified |
1 Months Ended | 12 Months Ended | |
---|---|---|---|
May 31, 2009
|
Dec. 31, 2013
Segment
|
Dec. 31, 2009
|
|
Summary Of Significant Accounting Policies [Line Items] | |||
Payment for original sublicense agreement | $ 12.0 | ||
Hatch-Waxman Extension | 5 years | ||
Upfront payment received under Fanapt sublicense agreement from Novartis | $ 200.0 | ||
Number of business segment | 1 |